-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
LIPELLA PHARMACEUTICALS INC. quarterly and annual Nonoperating Income (Expense) history and change rate from 2021 to Q3 2025.
- LIPELLA PHARMACEUTICALS INC. Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was $20,194, a 36.6% increase year-over-year.
- LIPELLA PHARMACEUTICALS INC. Nonoperating Income (Expense) for the twelve months ending 30 Sep 2025 was $80,201, a 15.9% decline year-over-year.
- LIPELLA PHARMACEUTICALS INC. annual Nonoperating Income (Expense) for 2024 was $64,278, a 49.4% decline from 2023.
- LIPELLA PHARMACEUTICALS INC. annual Nonoperating Income (Expense) for 2023 was $126,988.
- LIPELLA PHARMACEUTICALS INC. annual Nonoperating Income (Expense) for 2022 was $-7,979, a 116% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)